D
Revolution Medicines, Inc. RVMD
$39.12 $0.090.23%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue -- 742.00K 742.00K 4.57M 11.58M
Total Other Revenue -- -- -- -- --
Total Revenue -- 742.00K 742.00K 4.57M 11.58M
Cost of Revenue 470.64M 419.13M 375.11M 369.98M 320.91M
Gross Profit -470.64M -418.39M -374.37M -365.41M -309.33M
SG&A Expenses 96.72M 87.15M 78.71M 71.64M 62.02M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 689.52M 628.44M 575.98M 531.95M 473.27M
Operating Income -689.52M -627.70M -575.23M -527.39M -461.69M
Income Before Tax -600.85M -566.72M -522.73M -487.80M -439.89M
Income Tax Expenses -753.00K 343.00K -3.52M -3.52M -3.52M
Earnings from Continuing Operations -600.09 -567.06 -519.21 -484.27 -436.37
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -600.09M -567.06M -519.21M -484.27M -436.37M
EBIT -689.52M -627.70M -575.23M -527.39M -461.69M
EBITDA -683.00M -621.56M -569.47M -522.04M -456.68M
EPS Basic -3.57 -3.59 -3.65 -3.76 -3.77
Normalized Basic EPS -2.22 -2.12 -2.18 -2.25 -2.27
EPS Diluted -3.57 -3.59 -3.65 -3.76 -3.77
Normalized Diluted EPS -2.22 -2.12 -2.18 -2.25 -2.27
Average Basic Shares Outstanding 670.47M 637.90M 580.29M 522.03M 452.13M
Average Diluted Shares Outstanding 670.47M 637.90M 580.29M 522.03M 452.13M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings